Tokyo, Feb. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060574) titled 'Assessment of Fatigue in Head and Neck Cancer Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy: A Prospective Observational Study' on Feb. 10.
Study Type:
Observational
Primary Sponsor:
Institute - Tokyo Medical University
Condition:
Condition - Patients with head and neck cancer who received cisplatin-based concurrent chemoradiotherapy
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This study aimed to clarify the actual status of fatigue after cisplatin-based concurrent chemoradiotherapy in patients with head and neck cancer
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - i) Histological or cytological confirmation of head and neck cancer.
ii) Scheduled to complete cisplatin-based concurrent chemoradiotherapy.
iii) Able to understand written Japanese.
iv) Provided written informed consent after receiving a full explanation of the study.
Key exclusion criteria - i) Planned to receive subsequent treatment after chemoradiotherapy for head and neck cancer.
ii) Treated with radiotherapy alone (without concurrent chemotherapy).
iii) Deemed inappropriate for participation in this study by the attending physician.
Target Size - 100
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 06 Month 23 Day
Date of IRB - 2025 Year 12 Month 03 Day
Anticipated trial start date - 2025 Year 12 Month 03 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069121
Disclaimer: Curated by HT Syndication.
